VenoStent Secures $20 Million Series A Funding Including $4 Million Investment from Norwest Venture Partners
VenoStent, Inc., a leading innovator in medical devices aimed at enhancing outcomes for dialysis patients, has successfully closed its Series A funding round, securing $20 million. This round was highlighted by a significant $4 million investment from Norwest Venture Partners, alongside contributions from Good Growth Capital and IAG Capital Partners. Concurrently, the company has been…